Skip to content
Review

OneRF radiofrequency ablation system for the minimally invasive treatment of trigeminal neuralgia: initial clinical experience.

Oct 2026 · Pain Management · pp. 1-8 · 0 citations · 9 references
Medicine

Abstract

Background

Percutaneous radiofrequency ablation is an established treatment for medically refractory trigeminal neuralgia (TN). Conventional systems use a single active tip and often require repeated repositioning. A multi-contact radiofrequency platform may permit contact-level interrogation and lesioning along a single fixed trajectory.

Methods

We performed a retrospective review of patients with medically refractory TN treated with a multi-contact thin-film radiofrequency probe. Demographics, operative details, Barrow Neurological Institute (BNI) pain scores, medication use, and complications were reviewed. Contact-level localization was performed intraoperatively, including low-temperature thermal interrogation, followed by definitive lesioning.

Results

Fifteen patients (mean age 66.5 years; 12 women) underwent treatment. Most had classical or idiopathic TN, purely paroxysmal involving the V2-V3 distribution. Contact-level mapping was successfully achieved in all cases with definitive lesioning along a fixed trajectory. At mean follow-up of 6.0 months, all patients had a good outcome (BNI I-IIIB), and most had reduced or discontinued pain medications. No off-target lesioning was observed.

Conclusions

This early clinical series suggests that a multi-contact radiofrequency platform can facilitate contact-level mapping and lesioning of trigeminal distributions along a single trajectory without repeated probe repositioning. Initial pain outcomes were favorable, although larger cohorts and longer follow-up are needed to define durability and comparative effectiveness.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.